BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

MatriSys Bioscience

MatriSys Bioscience logo

Founded
2015
Geography
United States of America based
Funding
$1.500 M

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company focused on the $142 Billion WW dermatology and skin care market. We are developing therapies for the top 5 dermatology & skin care conditions - Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which have a huge impact on quality of life. More than 230 million patients suffer from these 5 skin diseases, which represent a $12.9 Billion Rx market and a $121 Billion skin care market.

MatriSys Bio’s scientific approach is to rebalance the natural skin microbiome by application of microbial therapies -“Good Bugs” that selectively target skin pathogens -“Bad Bugs”.

Technologies

Microbiome Startups  


Posts Mentioning This Company

Biopharma Insights

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet